Stock AnalizExponent Inc. EXPO
Professional Services · data as of November 13, 2026
Exponent Inc. (EXPO) is a consumer discretionary company listed in the US with a market value of about $4.2B. In the twelve months to October 2, 2026 it had revenue of $659M and net income of $115M, a net margin of 17.4%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is value (0/5).
Key numbers: a P/E of 37.6, a price to free cash flow of 29.5, 5-year revenue growth of 8% a year, a 5-year average ROIC of 22%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 48% below the current price.
Score: 2.6 / 5
Checks passed
- 3-year free cash flow growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $659M | $582M | $559M | $537M | $513M | $466M | $400M | $417M | $380M | $348M | $315M |
| Net income | $115M | $106M | $109M | $100M | $102M | $101M | $83M | $82M | $72M | $41M | $47M |
| Free cash flow | $141M | $122M | $138M | $111M | $82M | $118M | $98M | $85M | $75M | $63M | $53M |
| EPS (diluted) | $2.32 | $2.07 | $2.11 | $1.94 | $1.96 | $1.90 | $1.55 | $1.53 | $1.33 | $0.77 | $0.87 |
| Net margin | 17.4% | 18.2% | 19.5% | 18.7% | 19.9% | 21.7% | 20.6% | 19.8% | 19.0% | 11.9% | 15.1% |
| ROIC | — | 18.2% | 17.6% | 21.4% | 32.1% | 20.3% | 18.6% | 18.0% | 22.6% | 12.5% | 15.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $90.67, 4% above the current price; targets range from $82.00 to $100.00; the consensus rating is “none”; expected EPS is $2.57 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Exponent’s P/E ratio?
About 37.6, based on the last twelve months of diluted earnings per share (forward P/E about 30.2).
Is Exponent stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 48% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Exponent pay a dividend?
Yes. The dividend yield is about 1.44%, and it has paid dividends for 10 years in our data.
Is Exponent a good stock to buy?
We do not give buy or sell advice. Exponent scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.